Ibrutinib

What is Ibrutinib?

TYPES:Generic: IbrutinibBrand:

Ibrutinib is an experimental drug being tested for the purposes of treating cancers related to B-cells, which are a part of the immune system. This drug acts by inhibiting Bruton’s tyrosine kinase, a key component of the B-cell signalling pathway.

Save up to 80% off your prescriptions!

How do members experience Ibrutinib?

Top 5 reported purposes & perceived effectiveness

Purpose Patients Evaluations Perceived Effectiveness
Chronic lymphocytic leukemia 11 20
B cell prolymphocytic leukemia 2 6
Mantle cell lymphoma 2 1
Diffuse large B-cell lymphoma 1 0
Multiple myeloma 1 1

Common side effects

Side effect Patients Percentage
Diarrhea 3
Dry skin 2
Fatigue 2
Thrombocytopenia (low platelet count) 2
Autoimmune hemolytic anemia 1
Bleed easily 1

Side effect severity

Side effects as an overall problem
Severity Evaluations Percentage
Severe 4
Moderate 8
Mild 15
None 2
Learn more about our community’s experience with Ibrutinib

What are people saying about Ibrutinib?

70

70

members have reported taking Ibrutinib

Join the conversation and connect with people who have taken Ibrutinib
Last updated:

Save up to 80% off your prescriptions!

ADVERTISEMENT

ADVERTISEMENT